Home > Boards > US Listed > Biotechs > Aclaris Therapeutics, Inc. (ACRS)

You proved right about this stock since your

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
HappyLibrarian Member Profile
 
Followed By 8
Posts 3,573
Boards Moderated 1
Alias Born 03/29/15
160x600 placeholder
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 7/9/2019 5:11:52 PM
Aclaris Therapeutics Announces Issuance of Additional Orange Book Listable Patent Covering RHOFADEĀ® (Oxymetazoline Hydrochlo... GlobeNewswire Inc. - 7/9/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/3/2019 4:48:19 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 7/3/2019 4:47:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/3/2019 4:45:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/3/2019 4:16:30 PM
Aclaris Therapeutics Announces Appointment of Maxine Gowen to Board of Directors GlobeNewswire Inc. - 7/3/2019 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2019 5:03:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/26/2019 5:53:24 PM
Aclaris Therapeutics Announces Phase 2 Clinical Trial of ATI-502 Topical in Patients with Alopecia Areata Did Not Meet Endpoi... GlobeNewswire Inc. - 6/26/2019 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/25/2019 6:32:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/17/2019 6:16:16 AM
Aclaris Therapeutics Announces Positive 6-Month Results from a Phase 2 Open-Label Clinical Trial of ATI-502 Topical in Patien... GlobeNewswire Inc. - 6/17/2019 6:00:00 AM
Aclaris Therapeutics to Present at the 2019 JMP Securities Life Sciences Conference GlobeNewswire Inc. - 6/14/2019 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 5:48:02 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 4:57:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 4:53:21 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 4:51:51 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 4:50:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/10/2019 4:50:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/7/2019 7:01:54 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/5/2019 7:03:12 AM
Aclaris Therapeutics to Present at Jefferies 2019 Global Healthcare Conference GlobeNewswire Inc. - 5/24/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/13/2019 5:25:41 PM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 5/9/2019 4:59:31 PM
HappyLibrarian   Wednesday, 01/24/18 09:52:56 AM
Re: stocktrademan post# 1
Post # of 5 
You proved right about this stock since your post. I bought 20 shares at $25.04 today and I'll have to see if these guys can either handle commercialization or negotiate a decent buyout from Big Pharma. I was able to make some nice money for fairly little risk some time back on Athersys by buying after they got an FDA approval but before the buyout.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist